Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs Intravenous Magnesium Sulfate for PPHN
NCT06603766Phase 3Completed
- Sponsor
- Benha University
- Start
- Oct 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Benha University. Started Oct 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT06603766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06603766.